Background: Best practice for informed consent in aesthetic plastic surgery is a process of shared decision-making, yet evidence strongly suggests this is not commonly reflected in practice nor is it supported by traditional informed consent documents (ICD). Falsely held beliefs by clinicians about shared decision-making may contribute to its lack of adoption.Objective: The authors sought to understand the baseline attitudes, beliefs, and practices of informed consent among board-certified plastic surgeons with a primarily aesthetics practice.Methods: A 15-question online survey was emailed to active members of the American Society for Aesthetic Plastic Surgery. Items included demographics, Likert scales, free-text, acceptability, and 1 question seeking consensus on general information all patients must understand before any surgery.Results: This survey yielded a 13% response rate with a 52% completion rate across 10 countries and 31 US states. A total of 69% were very or extremely confident that ICD contain evidence-based information, but 63% were not at all or not so confident in ICD effectiveness of prompting patients to teach-back essential information. A total of 50% believed surgical ICD should be reviewed annually. Eighty-six percent reported assistance with patient education during informed consent. Members of professional plastic surgery societies should be a source of evidence for content (free-text). A total of 64% were somewhat to very satisfied with the survey and 84% will probably to definitely participate in future related surveys.Conclusions: The findings echo concerns in the literature that ICD are focused on disclosure instead of patient understanding. There is notable concern regarding information overload and retention but less regarding the quality and completeness of information. Current culture suggests key clinician stakeholders are amenable to change.
What constitutes adequate information for decision-making and informed consent is a practical question appropriately answered with deference to expertise. The specific objectives were to (1) establish consensus on a procedure-specific core information set of essential informed consent information by relevant medical experts for primary breast augmentation surgery and (2) to define from the clinical perspective, the data source and imminence elements of evidence-based risk communication. The study follows a modified Delphi expert consensus model. Active members of The Aesthetic Society were identified as the relevant clinician experts and were recruited by email. Survey round one was informed by a scoping review of the relevant scientific and gray literature. Round two was informed by the initial survey round. Consensus was defined a priori as a 75% majority rating. Expert consensus of essential information was achieved for 16 risks, 1 risk factor and 8 expectations—including benefits and burdens, along with clarification of clinically appropriate options to present to all patients considering primary implant-based breast augmentation surgery. A basic, procedure-specific, structure for evidence-based risk data is also described. This paper reports results for the first phase of a larger pilot study aiming to develop a patient decision aid to replace traditional informed consent documents for the specified procedure. Implications for practice are encouraging toward reducing unwanted variation in disclosure practices and information overload.
The medical device industry is an incredibly profitable and rapidly growing sector of health care. In plastic surgery, the nonsurgical medical aesthetic device industry presents ongoing ethical challenges, specifically related to the principles of nonmaleficence and respect for autonomy. The purpose of this article is to increase awareness of the ethical challenges the nonsurgical medical aesthetic device industry presents, including use of deceptive or misleading language in advertising, limited evidence of efficacy, and lack of public and professional understanding of the U.S. Food and Drug Administration regulation of medical devices. Practical application of ethics is presented through the lens of the Code of Ethics for Nurses With Interpretive Statements (American Nurses Association, 2015) and the Code of Ethics of the American Society for Aesthetic Plastic Surgery (American Society for Aesthetic Plastic Surgery, 2017).